{"schema_version":"secwatch.filing_event.v1","accession":"0001656423-22-000018","form_type":"8-K","ticker":"BXP","cik":"0001037540","company_name":"BXP, Inc.","filed_at":"2022-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.414987+00:00","generated_at":"2026-06-26T01:52:32.829023+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Boston Properties Q1 EPS $0.91 beats guidance; FFO $1.82; acquires Seattle tower for ~$730M","bullets":["Q1 revenue $754.3M (+6% YoY); net income $143M ($0.91 EPS) vs $91.6M ($0.59) prior year.","FFO $1.82/share, exceeding mid-point guidance; driven by portfolio performance and reinstated accrual accounting.","Executed 1.2M SF of leases in Q1 (double YoY); including 330K SF renewal at 601 Lexington Ave, NY.","Agreed to acquire Madison Centre in Seattle for ~$730M; signed 570K SF lease with AstraZeneca in Cambridge, MA.","FY 2022 guidance: EPS $5.32-$5.42; FFO $7.40-$7.50; Q2 EPS $0.79-$0.81; FFO $1.84-$1.86."],"urls":{"canonical":"https://secwatch.observer/filing/0001656423-22-000018","json":"https://secwatch.observer/filing/0001656423-22-000018.json","markdown":"https://secwatch.observer/filing/0001656423-22-000018.md","text":"https://secwatch.observer/filing/0001656423-22-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1037540/000165642322000018/0001656423-22-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1037540/000165642322000018/bxp-20220502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T01:52:32.829023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}